FHND1002 for ALS Treatment: Phase 2

Clinical trial NCT07138014 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07138014
Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-10-01
Primary completion: 2027-12-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.